Vesselon Spv Llc Company Profile
✉ Email this page to a colleague
What is the competitive landscape for VESSELON SPV LLC, and what generic and branded alternatives to VESSELON SPV LLC drugs are available?
VESSELON SPV LLC has one approved drug.
Drugs and US Patents for Vesselon Spv Llc
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Vesselon Spv Llc | IMAGENT | dimyristoyl lecithin; perflexane | INJECTABLE;INTRAVENOUS | 021191-001 | May 31, 2002 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | |||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for Vesselon Spv Llc
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Vesselon Spv Llc | IMAGENT | dimyristoyl lecithin; perflexane | INJECTABLE;INTRAVENOUS | 021191-001 | May 31, 2002 | 5,695,741 | ⤷ Sign Up |
Vesselon Spv Llc | IMAGENT | dimyristoyl lecithin; perflexane | INJECTABLE;INTRAVENOUS | 021191-001 | May 31, 2002 | 6,280,705 | ⤷ Sign Up |
Vesselon Spv Llc | IMAGENT | dimyristoyl lecithin; perflexane | INJECTABLE;INTRAVENOUS | 021191-001 | May 31, 2002 | 5,605,673 | ⤷ Sign Up |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Similar Applicant Names
Here is a list of applicants with similar names.